Additionally, stricter adherence to treatment protocols among females could partly explain their greater weight reduction [55]
Red Flags Indicating Potential Quality Concerns: Sources Outside Legitimate Medical Channels: Injectable products obtained from online marketplaces, international sources without proper medical oversight, or vendors operating outside pharmaceutical regulatory frameworks carry substantial risks including contamination, incorrect concentration, inappropriate formulation, lack of sterility, and absence of medical oversight
Healthy young dogs with no medical conditions: It is not usually aimed at pets that have no long-term problems and do not have injuries or other recovery requirements
Manufacturers are responsible for their own safety and labeling
You can learn more in our Overview of GLP1 SideEffects
Retatrutide In Phase 2 trials, Retatrutide produced: Up to 24.2% weight loss after 48 weeks at higher doses Strong dose dependent responses across study groups A proportion of participants lost 15% or more of their body weight, particularly at the upper dose ranges